Go back

Go to
Antoine Faguer

“An exciting aspect of working in Private Equity is undoubtedly the exit strategy. Planning a strategic exit right from the investment phase allows us to align our value-added strategies, making the companies as appealing as possible. Our plug-and-play approach is especially appreciated by strategic buyers looking to swiftly expand their presence with a dedicated (ready-to-roll) business unit.”



Sector: MedTech


Antoine joined ARCHIMED in 2018 bringing over 10 years of experience in private equity, where he completed several transactions in the healthcare sector.

Antoine began his career at BNP Paribas and went on to join 3i in 1999, where he spent nine years. Between 2004 and 2007, he took an operational role as the CFO of Norac Group, an agrifood company, where he led several M&A activities and contributed to the company’s growth. From 2011, he took on the role of CEO in an entrepreneurial project, which involved acquiring an industrial group and expanding it through both organic growth and acquisitions.

Antoine has a long-standing relationship with other ARCHIMED partners since 2001.

He is currently leading ARCHIMED’s investment in the UK-based manufacturer of hospital equipment, Direct Healthcare Group (DHG), France-based testing service provider, CARSO and Germany-based Contract Manufacturing Organization (CMO) for complex plasmid DNA, PlasmidFactory.


Direct Healthcare Group